Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter

Libuše Smetanová, Věra Štětinová, Zbyněk Svoboda, Jaroslav Květina

. 2011 ; 54 (1) : 3-8.

Language English Country Czech Republic

The Caco-2 cell monolayer model is widely used as a standard screening tool for studying the mechanisms of cellular drug transport. Caffeine was chosen as a model drug and is supposed to be class I of the Biopharmaceutics Classification System (BCS). Our study was conducted 1) to characterize the mechanisms of caffeine transport across the intestinal barrier, 2) to classify caffeine according to BCS, 3) to predict drugs intestinal absorption in humans. METHODS: Caffeine transport (0.1, 0.3, 1 and 10 mmol/l) was studied in Caco-2 cell monolayer in apical to basolateral (AP-BL) and basolateral to apical (BL-AP) direction, under iso-pH 7.4 and pH-gradient (6/7.4) conditions. The relative contribution of the paracellular route was estimated using Ca2+- free transport medium (opening tight junctions). RESULTS: The caffeine transport was linear with time, transport direction and pH independent, displaying non-saturable (first-order) kinetics, with high permeability coefficient (Papp): in AP-BL direction Papp = 46.3-53.5 x 10-6 cm/s; in BL-AP direction Papp = 45.6-49.4 x 10-6 cm/s. Thus, the transport seems to be transcellular mediated by passive diffusion. Using Ca2+- free transport medium tight junctions were opened (confirmed by increased Papp of mannitol) but the caffeine Papp was not changed. Thus, the paracellular route is only a minor way of caffeine transport. CONCLUSION: High solubility and high permeability of caffeine rank it among class I of BCS and well absorbed compounds

References provided by Crossref.org

Bibliography, etc.

Lit.: 34

000      
00000naa 2200000 a 4500
001      
bmc11008366
003      
CZ-PrNML
005      
20111210203709.0
008      
110428s2011 xr e eng||
009      
AR
024    7_
$a 10.14712/18059694.2016.9 $2 doi
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Smetanová, Libuše $7 xx0139464
245    10
$a Caco-2 Cells, Biopharmaceutics Classification System (BCS) and Biowaiter / $c Libuše Smetanová, Věra Štětinová, Zbyněk Svoboda, Jaroslav Květina
314    __
$a Institute of Experimental Biopharmaceutics, Czech Academy of Sciences, Czech Republic. smetanova@uebf.cas.cz
504    __
$a Lit.: 34
520    9_
$a The Caco-2 cell monolayer model is widely used as a standard screening tool for studying the mechanisms of cellular drug transport. Caffeine was chosen as a model drug and is supposed to be class I of the Biopharmaceutics Classification System (BCS). Our study was conducted 1) to characterize the mechanisms of caffeine transport across the intestinal barrier, 2) to classify caffeine according to BCS, 3) to predict drugs intestinal absorption in humans. METHODS: Caffeine transport (0.1, 0.3, 1 and 10 mmol/l) was studied in Caco-2 cell monolayer in apical to basolateral (AP-BL) and basolateral to apical (BL-AP) direction, under iso-pH 7.4 and pH-gradient (6/7.4) conditions. The relative contribution of the paracellular route was estimated using Ca2+- free transport medium (opening tight junctions). RESULTS: The caffeine transport was linear with time, transport direction and pH independent, displaying non-saturable (first-order) kinetics, with high permeability coefficient (Papp): in AP-BL direction Papp = 46.3-53.5 x 10-6 cm/s; in BL-AP direction Papp = 45.6-49.4 x 10-6 cm/s. Thus, the transport seems to be transcellular mediated by passive diffusion. Using Ca2+- free transport medium tight junctions were opened (confirmed by increased Papp of mannitol) but the caffeine Papp was not changed. Thus, the paracellular route is only a minor way of caffeine transport. CONCLUSION: High solubility and high permeability of caffeine rank it among class I of BCS and well absorbed compounds
650    _2
$a financování organizované $7 D005381
650    _2
$a biologický transport $x fyziologie $x účinky léků $7 D001692
650    _2
$a Caco-2 buňky $7 D018938
650    _2
$a kofein $x farmakokinetika $x farmakologie $7 D002110
650    _2
$a buněčné kultury $7 D018929
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a difuze $7 D004058
650    _2
$a lidé $7 D006801
650    _2
$a koncentrace vodíkových iontů $7 D006863
650    _2
$a intestinální absorpce $7 D007408
650    _2
$a střevní sliznice $x metabolismus $7 D007413
650    _2
$a kinetika $7 D007700
650    _2
$a lineární modely $7 D016014
650    _2
$a mannitol $x metabolismus $7 D008353
650    _2
$a permeabilita $x účinky léků $7 D010539
650    _2
$a těsný spoj $x metabolismus $x účinky léků $7 D019108
650    _2
$a xenobiotika $x farmakokinetika $x farmakologie $7 D015262
700    1_
$a Štětinová, Věra $7 xx0117623
700    1_
$a Svoboda, Zbyněk $7 xx0081965
700    1_
$a Květina, Jaroslav, $d 1930- $7 jk01071205
773    0_
$w MED00010947 $t Acta medica (Hradec Králové) $g Roč. 54, č. 1 (2011), s. 3-8 $x 1211-4286
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/am_2011054010003.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 1
990    __
$a 20110428135242 $b ABA008
991    __
$a 20111101114428 $b ABA008
999    __
$a ok $b bmc $g 836275 $s 700566
BAS    __
$a 3
BMC    __
$a 2011 $b 54 $c 1 $d 3-8 $m Acta Medica $x MED00010947
LZP    __
$a 2011-07/mkme

Find record

Citation metrics

Loading data ...